Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1609, 2007-01, pp. : 23-23
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US FDA issues not approvable letter for istradefylline.
Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. :
Access to resources
Recommend
The prasugrel new drug application (NDA) is still under discussion with the US FDA
Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. :
Letter From the Commissioner's Office at the US FDA
PharmacoEconomics, Vol. 25, Iss. 2, 2007-01 ,pp. :
Letter From the Commissioner's Office at the US FDA
PharmacoEconomics, Vol. 25, Iss. 1, 2007-01 ,pp. :